分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Targeting IL-1β to inhibit neutrophil extracellular traps improves meningeal lymphatic dysfunction in cerebral venous sinus thrombosis

Jun Li, Jianbin Ying, Hao Zhang, Zhenhong Pan, Yang Yang, Haibing Liu, Yinxing Huang, Liangfeng Wei, Lin Zhao, Junjie Jing, Shousen Wang

Journal:INTERNATIONAL IMMUNOPHARMACOLOGY

IF:5.6

DOI:10.1016/j.intimp.2026.116762

PMID:42085845

Published:2026-05-04

research field:神经病学免疫学炎症脑血管病淋巴生物学

Abstract

Cerebral venous sinus thrombosis (CVST) is a rare but serious cerebrovascular disorder. Although meningeal lymphatic vessels (MLVs) play a critical role in cerebrospinal fluid (CSF) clearance and neuroimmune regulation, their contribution to CVST pathophysiology remains unclear. Here, we established a FeCl 3 -induced CVST mouse model to investigate the role of MLV dysfunction. CVST mice exhibited impaired lymphatic drainage and neurological deficits. Ligation of MLVs further aggravated brain damage, and RNA-seq analysis identified activation of the IL-1β pathway as a key contributor. Mechanistically, neutrophils infiltrated MLVs in CVST mice and released neutrophil extracellular traps (NETs), which potentially contributing to lymphatic vessel apoptosis and reduced clearance efficiency. Therapeutic disruption of NETs with DNase I or the blockade of IL-1β signaling with IL-1 receptor antagonist (IL-1RA) preserved MLV integrity, improved CSF clearance, and ameliorated brain injury and behavioral impairments in CVST mice. Together, these findings identify the IL-1β–NET axis as a critical mediator of MLV dysfunction in CVST and highlight potential therapeutic targets to mitigate brain injury.

本文使用的Yeasen产品

购物车
客服
转染试用